target_layer1_structure: A0A075B5G3
This data as json
| target_id | pdb_count_total | pdb_count_detailed | pdb_best_resolution_A | alphafold_mean_pLDDT | alphafold_model_count | emdb_count | has_cryoEM | has_xray | has_NMR | raw_json | recorded_utc |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A0A075B5G3 | 1 | 1 | 82.75 | 1 | 0 | 0 | 1 | 0 | {"pdb": {"uniprot_id": "A0A075B5G3", "pdb_count_total": 1, "pdb_count_detailed": 1, "entries": [{"pdb_id": "4OV6", "title": "Crystal structure of PCSK9(53-451) with Adnectin", "keywords": "HYDROLASE/PROTEIN BINDING", "resolution": 2.69, "method": "X-RAY DIFFRACTION", "deposit_date": "2014-02-20T00:00:00.000+00:00", "release_date": "2014-07-02T00:00:00.000+00:00", "my_uniprot_chains": [{"entity_id": "3", "chains": ["F", "G"], "description": "Adnectin", "length": 99}], "ligands": [{"comp_id": "1,2-ETHANEDIOL", "chem_id": "EDO"}, {"comp_id": "TETRAETHYLENE GLYCOL", "chem_id": "PG4"}], "primary_citation": {"title": "Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering.", "doi": null, "pmid": null, "journal": "J Pharmacol Exp Ther", "year": 2014, "authors": ["Mitchell, T.", "Chao, G.", "Sitkoff, D.", "Lo, F.", "Monshizadegan, H.", "Meyers, D."]}, "related_emdb": []}]}, "alphafold": {"uniprot_id": "A0A075B5G3", "model_count": 1, "models": [{"entryId": "AF-A0A075B5G3-F1", "uniprotAccession": "A0A075B5G3", "uniprotDescription": "Adnectin", "organismScientificName": "Homo sapiens", "sequenceLength": null, "globalMetricValue": 82.75, "modelCreatedDate": "2022-06-01T00:00:00Z", "latestVersion": 6, "cifUrl": "https://alphafold.ebi.ac.uk/files/AF-A0A075B5G3-F1-model_v6.cif", "pdbUrl": "https://alphafold.ebi.ac.uk/files/AF-A0A075B5G3-F1-model_v6.pdb", "paeImageUrl": "https://alphafold.ebi.ac.uk/files/AF-A0A075B5G3-F1-predicted_aligned_error_v6.png"}]}, "emdb": {"uniprot_id": "A0A075B5G3", "emdb_count": 0, "entries": []}} | 2026-05-27T10:45:01.877649+00:00 |